Work

A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of TPN171 (a PDE5 Inhibitor) in Adults with Renal Impairment

Year: 2025

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology in Drug Development

DOI: 10.1002/cpdd.1536

Authors: Ping Fu, Yi Song, Chao Hu, Xiaolan Yong, Yang Yu, Yi Chen, Ying Wang, Xiaohong Zhu, Zhen Wang, Yu Wang, Jiaxiang Juan, Yuan Chen, Jia Miao

Institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, North Sichuan Medical University, Vigonvita Life Sciences Co., Ltd. (China), Chinese Academy of Sciences, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research

Language: English

Topic: Sexual function and dysfunction studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409649265

FWCI:

Cites: 18

Cited by:

Related to: 10